Sandmell Pharmaceuticals Private Limited - Company Profile

It is a home appliances private limited company based in New Delhi, Delhi, India, established in 2012.
2012 New Delhi, Delhi, India Struck Off
Last Updated:
About Sandmell Pharmaceuticals Private Limited

Sandmell Pharmaceuticals Private Limited, a struck off private limited company, was established on 18 December 2012 in New Delhi, Delhi, India. Engaging in wholesale within the home appliances sector, it holds CIN: U51397DL2012PTC246363. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

Its leadership includes Veerendranad Benarji Mabbu (Director), Reena Savitha Monis (Director). Past directors included Satyendra Kumar Singh, Jyoti Loomba, Veerendranad Benarji Mabbu. It is based at Office No.101,102,50 Community Center, Naraina Industrial Area,Phase-I, New Delhi, Delhi, 110028.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U51397DL2012PTC246363

  • Registration Number

    246363

  • Incorporation Date

    18 December 2012

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 13 Year, 2 Months
Company report

Sandmell Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Sandmell Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Sandmell Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Veerendranad Benarji Mabbu Director 21 Sep 2017 Current
Reena Savitha Monis Director 21 Sep 2017 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 22 Sep 2017 Past
Pramod Abcsdd Director 22 Sep 2017 Past
Pramod Abcsdd Additional Director 26 Sep 2017 Past
Pramod Abcsdd Director 22 Sep 2017 Past
Pramod Abcsdd Additional Director 26 Sep 2017 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Sandmell Pharmaceuticals.

Enhance accessibility to Sandmell Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Sandmell Pharmaceuticals revenue growth over time
Sandmell Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Sandmell Pharmaceuticals?

Unlock access to Sandmell Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Sandmell Pharmaceuticals?

Unlock and access historical data on people associated with Sandmell Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Sandmell Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sandmell Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Sandmell Pharmaceuticals
Recent Activity within the Organization
  • Director Appointment

    Progress on Veerendranad Benarji Mabbu was appointed as a Director was appointed as a Director on 21 Sep 2017 & has been associated with this company since 8 years 5 months . was documented.

  • Director Appointment

    Progress on Reena Savitha Monis was appointed as a Director was appointed as a Director on 21 Sep 2017 & has been associated with this company since 8 years 5 months . was documented.

  • Company Incorporation

    Sandmell Pharmaceuticals Private Limited was registered on 18 Dec 2012 with Roc Delhi & aged 13 years 2 months as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Sandmell Pharmaceuticals Private Limited?

The CIN of Sandmell Pharmaceuticals Private Limited is U51397DL2012PTC246363.

Where is Sandmell Pharmaceuticals Private Limited headquartered?

Sandmell Pharmaceuticals Private Limited is headquartered at Office No.101,102,50 Community Center, Naraina Industrial Area,Phase-I, New Delhi, Delhi, 110028.

When was Sandmell Pharmaceuticals Private Limited incorporated?

Sandmell Pharmaceuticals Private Limited was incorporated on 18 December 2012.

Who are the current directors of Sandmell Pharmaceuticals Private Limited?

The current directors of Sandmell Pharmaceuticals Private Limited are

What is the primary industry of Sandmell Pharmaceuticals Private Limited?

The primary industry of Sandmell Pharmaceuticals Private Limited is Home Appliances.

Is Sandmell Pharmaceuticals Private Limited a listed company?

Sandmell Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Sandmell Pharmaceuticals Private Limited?

The authorized capital of Sandmell Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available